1. Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial. Issue 6 (June 2019) Authors: Xu, Peng-Peng; Fu, Di; Li, Jian-Yong; Hu, Jian-Da; Wang, Xin; Zhou, Jian-Feng; Yu, Hao; Zhao, Xia; Huang, Yao-Hui; Jiang, Lu; Liu, Feng; Su, Li-Ping; Chen, Zhuo-Wen; Zeng, Qing-Shu; Chen, Jie-Ping; Fang, Mei-Yun; Ma, Jun; Liu, Ting; Song, Yong-Ping; Yu, Kang Journal: Lancet Issue: Volume 6:Issue 6(2019) Page Start: e328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells. (28th June 2016) Authors: Han, Lu; Shang, Yi-Man; Song, Yong-Ping; Gao, Quan-Li Other Names: Shanker Anil Academic Editor. Journal: Journal of immunology research Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial. Issue 7 (July 2018) Authors: Zhu, Hong-Hu; Wu, De-Pei; Du, Xin; Zhang, Xi; Liu, Lin; Ma, Jun; Shao, Zong-Hong; Ren, Han-Yun; Hu, Jian-Da; Xu, Kai-Lin; Wang, Jing-Wen; Song, Yong-Ping; Fang, Mei-Yun; Li, Juan; Yan, Xiao-Yan; Huang, Xiao-Jun Journal: Lancet oncology Issue: Volume 19:Issue 7(2018) Page Start: 871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗